EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

Autor: V. A. Kel'tsev, L. I. Grebenkina, N. S. Pryanichkova, S. А. Gorunov, N. V. Lagoda
Jazyk: English<br />Russian
Rok vydání: 2012
Předmět:
Zdroj: Вопросы современной педиатрии, Vol 11, Iss 6, Pp 103-109 (2012)
Druh dokumentu: article
ISSN: 1682-5527
1682-5535
DOI: 10.15690/vsp.v11i6.500
Popis: The results of efficacy and safety study of abatacept and methotrexate combination therapy (n=12) in comparison with methotrexate monotherapy (n =41) in patients with polyarticular juvenile idiopathic arthritis at the age of 4–17 years old are shown in this article. The duration of the observation was 1 year. Abatacept was introduced at a dose of 10 mg/kg at 1st, 2d and then — every 4th week. In 48 weeks clinical remission and decrease of laboratory markers of activity was registered in 35% of patients treated with abatacept and methotrexate and in 16% of patients treated only with methotrexate.
Databáze: Directory of Open Access Journals